World's Best Scientists 2026 revealed!
Mario Cazzola

Mario Cazzola

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
129
Citations
85373
World Ranking
2532
National Ranking
57

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Mario Cazzola is affiliated with the University of Pavia in Italy and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research primarily focuses on hematology, genetics, molecular biology, pulmonary and respiratory medicine, and physiology.

Their main areas of study include:

  • Hematology
  • Genetics
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Physiology

Key research topics covered in their work are:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Chronic Myeloid Leukemia Treatments
  • Kruppel-like factors research
  • Blood disorders and treatments

Mario Cazzola has published in several reputable venues, reflecting their research scope. Frequent publication platforms include:

  • Blood
  • Leukemia
  • Blood Advances
  • Nature Medicine
  • American Journal of Hematology

Among recent significant publications are:

  • Myelodysplastic Syndromes, 2020, New England Journal of Medicine
  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data, 2022, Blood
  • Molecular International Prognostic Scoring System for Myelodysplastic Syndromes, 2022, NEJM Evidence
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes, 2020, Nature Medicine
  • Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes, 2020, New England Journal of Medicine

The scientist has collaborated frequently with a number of researchers including:

  • Luca Malcovati
  • Robert P. Hasserjian
  • Seishi Ogawa
  • Elsa Bernard
  • Michael R. Savona

Mario Cazzola has contributed a substantial volume of work, with 137 publications in Medicine and 35 in Biochemistry, Genetics and Molecular Biology. Their research outputs emphasize the intersection of clinical applications and molecular insights into hematologic malignancies and related disorders.

Best Publications

  • The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

    Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele

  • A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

    Robert Kralovics;Francesco Passamonti;Andreas S. Buser;Soon Siong Teo

  • Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

    Thorsten Klampfl;Heinz Gisslinger;Ashot S Harutyunyan;Harini Nivarthi

  • Clinical and biological implications of driver mutations in myelodysplastic syndromes.

    Elli Papaemmanuil;Moritz Gerstung;Luca Malcovati;Sudhir Tauro

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

    E. Papaemmanuil;M. Cazzola;J. Boultwood;L. Malcovati

  • Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

    Luca Malcovati;Ulrich Germing;Andrea Kuendgen;Matteo G. Della Porta

  • Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

    Luca Malcovati;Matteo Giovanni Della Porta;Cristiana Pascutto;Rosangela Invernizzi

  • Mutations and prognosis in primary myelofibrosis

    Alessandro Maria Vannucchi;Tl Lasho;Paola Guglielmelli;Flavia Biamonte

  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Francesco Passamonti;Francisco Cervantes;Alessandro Maria Vannucchi;Enrica Morra

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

    Elisa Rumi;Daniela Pietra;Virginia Ferretti;Thorsten Klampfl

  • Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia

    Francesco Passamonti;Elisa Rumi;Ester Pungolino;Lucia Malabarba

  • Gene mutations and treatment outcome in chronic lymphocytic leukemia: Results from the CLL8 trial

    Stephan Stilgenbauer;Andrea Schnaiter;Peter Paschka;Thorsten Zenz;Thorsten Zenz

  • Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

    Luca Malcovati;Elli Papaemmanuil;David T. Bowen;Jacqueline Boultwood

  • A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

    Pierre Fenaux;Aristoteles Giagounidis;Dominik Selleslag;Odile Beyne-Rauzy

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

Frequent Co-Authors

Francesco Passamonti
Francesco Passamonti University of Milan
Daniela Pietra
Daniela Pietra University of Pavia
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital
Paola Guglielmelli
Paola Guglielmelli University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Andrea Pellagatti
Andrea Pellagatti University of Oxford
Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute
Francisco Cervantes
Francisco Cervantes University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn’t always mean attending medical school right away. Many healthcare professionals start their journey through related online degrees, which offer flexibility, affordability, and valuable career skills.

For example, those interested in administrative roles can consider programs like the average cost of medical billing and coding program. These courses are usually budget-friendly and take less time to complete, helping you enter the workforce quickly.

If you’re aiming for patient care, there are affordable options to pursue a nursing degree online. Registered nurses are in high demand and an online route offers flexibility for working students.

For those looking to advance further, affordable graduate degrees are available for nurses. Consider the cheapest fnp programs to become a family nurse practitioner, or the cheapest dnp programs online for a Doctor of Nursing Practice (DNP) degree.

Each of these options can open the door to rewarding healthcare careers—whether at the bedside, in clinics, or even in leadership roles.

Best Scientists Citing Mario Cazzola

Trending Scientists